Supreme Court Issues Long-Awaited Decisions in Oil States

New Post Public Reply Private Reply Replies (0) Message Board
CyberC gimli #29236
678
Supreme Court Issues Long-Awaited Decisions in Oil States and SAS Institute
April 24, 2018
Practices: Intellectual Property, Patent Trial & Appeal Board (PTAB) Proceedings
Printer-Friendly Version

On April 24, 2018, the U.S. Supreme Court handed down two decisions that have a significant impact on inter partes review proceedings before the Patent Trial and Appeal Board (“PTAB”) of the U.S. Patent and Trademark Office (“USPTO”). These proceedings review the patentability of patent claims previously issued by the USPTO.

The Court in Oil States Energy Services v. Greene’s Energy Group (decision here) found that these proceedings do not violate Article III or the Seventh Amendment because patents are public rights for purposes of this question. The Court in SAS Institute v. Iancu (decision here) found that the PTAB’s past practice of instituting review of fewer than all challenged claims violated the plain language of 35 U.S.C. § 318(a), which requires the PTAB to decide the patentability of all claims challenged in a petition.

Neither decision was unanimous, reflecting a rare divide among the Court in addressing patent issues. In Oil States, a 7-2 decision, Justice Thomas wrote for the majority; Justice Breyer wrote a concurring opinion joined by Justices Ginsburg and Sotomayor; and Justice Gorsuch wrote a dissent joined by Chief Justice Roberts. In SAS, a 5-4 decision, Justice Gorsuch wrote for the majority; Justice Ginsburg wrote a dissent joined by Justices Breyer, Sotomayor, and Kagan; and Justice Breyer also wrote a dissent joined by Justices Ginsburg and Sotomayor, and Justice Kagan in part.

Oil States: Inter Partes Review Trial Proceedings Are Constitutional Under Article III and the Seventh Amendment
Oil States had been involved in a patent infringement suit against Greene’s Energy Group, who filed an IPR petition challenging claims of the asserted patent. Ultimately, the PTAB held that the claims were unpatentable. Oil States then appealed the decision to the Federal Circuit and eventually to the Supreme Court, arguing in part that the inter partes review proceedings were contrary to Article III and the Seventh Amendment of the U.S. Constitution.

At the Supreme Court, Oil States argued that Article III, which vests the “judicial power of the United States” in the courts, prohibits the PTAB—a non-Article III forum—to extinguish private property rights in an adversarial proceeding such as an IPR. Oil States also argued that the Seventh Amendment’s jury trial right prohibits the PTAB from deciding issues of patentability. Despite previously denying several other similar petitions for certiorari, the Supreme Court granted Oil States’ petition, agreeing to review the constitutional questions presented. After several months of briefing, oral argument took place on November 27, 2017. Fifty-seven (57) briefs amicus curiae were filed at the merits stage, showing the intense public interest in the Court’s decision. In addition, the U.S. government also submitted briefing to the Court, in which it argued for the constitutionality of inter partes review, and participated in the oral argument.

Today, after a nearly five-month wait, the Supreme Court issued its decision affirming the Federal Circuit and upholding the constitutionality of IPR proceedings. In writing for the Court, Justice Thomas explained that patents convey a specific type of right—a “public franchise”—and that the reevaluation of the patentability of claims by the USPTO involves an adjudication of public rights. As such, the Court found that IPRs are not an improper exercise of the judicial power under either Article III of the Constitution or a violation of the right to a jury trial under the Seventh Amendment.

The Court’s affirmance of the status quo in Oil States is therefore unlikely to lead to any changes at the PTAB. However, the Court did emphasize the narrowness of its decision, noting that it was not addressing any retroactive issues associated with PTAB proceedings and reaffirming prior holdings are property protected by other provisions of the Constitution, such as the Fifth Amendment. Thus, the door may be open for possible future constitutional challenges.

SAS Institute: Partial Institution of Petitions Is Not Authorized
Although Oil States has garnered more attention than SAS, which was argued the same day, the Court’s decision in SAS will have significant impact on PTAB proceedings going forward. Section 314(a) of Title 35 states that the USPTO Director may not institute review unless the Director determines that “there is a reasonable likelihood that the petitioner would prevail with respect to at least 1 of the claims challenged in the petition.” If review is instituted, Section 318(a) states that the USPTO Director “shall issue a final written decision with respect to the patentability of any patent claim challenged by the petitioner and any new claim added under section 316(d).” Despite this directive, the PTAB only instituted review and issued a final written decision on a subset of the claims that SAS initially challenged. The Federal Circuit affirmed the PTAB’s practice of so-called “partial institution,” holding that the final written decision need only address the claims under review post-institution. The Supreme Court, however, found that the language of the statute is clear—SAS was entitled to a final written decision addressing all of the claims it has challenged, reversing the Federal Circuit and remanding the case for further proceedings.

The situation in SAS is not uncommon. Among the 4,000+ decisions instituting review to date, the PTAB has generally instituted review—and subsequently issued final written decisions—only on the particular claims for which the petitioner has shown that there is a reasonable likelihood that it would prevail at institution. While the USPTO has not released specific statistics, and a majority of these decisions have instituted as to all challenged claims, a significant number of these decisions have instituted as to fewer than all challenged claims.

The Court’s decision today raises important questions and issues going forward. For example, the Federal Circuit and the PTAB will need to address the impact of SAS on proceedings already subject to partial institutions, both before and after a final written decision has issued. The PTAB may also adjust the role that institution decisions will play if these decisions cannot narrow the number of claims at issue, because final written decisions must address all challenged claims. For example, rather than issuing detailed institution decisions with substantive analysis regarding all challenged claims, the PTAB may instead choose to issue a simplified notice of institution containing minimal, if any, information useful to the parties. Relatedly, petitioners and patent owners litigating before the PTAB will need to adjust their respective strategies in light of SAS and any changes in the PTAB’s practices. For example, because the issuance of a final written decision as to a claim triggers estoppel provisions under Section 315(e), petitioners will need to assess the impact of SAS if all challenged claims will be subject to a final written decision if the proceeding is instituted regardless of the likelihood of success as to each claim. Conversely, patent owners will likely adjust pre-institution strategies to focus attacks on the broadest claims and abandon prior practices attempting to avoid institution as to fewer than all of the challenged claims.

Short of legislative action or additional regulatory workarounds that attempt to maintain more of the status quo, the decision in SAS will significantly alter practice before the PTAB going forward.

We will continue to monitor further developments regarding the impact of these decisions. If you have any questions about this Alert, please contact Scott McKeown, Gabrielle Higgins, James Davis or Matthew Rizzolo.

Zerify Inc (ZRFY) Stock Research Links

ZRFY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ractigen's LiCO™ Platform Hits Extrahepatic Milestones

Updated Category News Views 27

Breaking New Ground in RNA Therapeutics Hey, in the world of biotech, landing a meaningful delivery system is like striking gold, and it seems Ractigen Therapeutics just found a shiny nugget. Their latest study on the LiCO™ platform, living and breathing in the pages of Molecular Therapy - Nucleic Acids, maps out a path to some serious therapeutic territory. These guys...

Continue Reading
Divorce Expertise: Obenhaus Adds CDFA Credential

Updated Category News Views 46

Divorce isn't just a legal tangled mess; it's a financial minefield as well. Lindsey Obenhaus from Goranson Bain Ausley has beefed up her credentials with a Certified Divorce Financial Analyst® (CDFA®) designation, lending a sharper edge to her approach in divorce financials. When relationships turn sour, so do wallets, and Obenhaus aims to soften that blow for her...

Continue Reading
Veterans Find Community and Wellness at Orland Hills Bash

Updated Category News Views 16

A Celebration of Veterans and Community Orland Hills is set to light up with a unique Veterans Day Bash on November 1, 2026. This isn't just your run-of-the-mill community gathering; it's an event that brings together veterans from all around for a day packed with resources, education, and a chance to connect with kindred spirits—all thanks to the collaboration between...

Continue Reading
Enigmata Innovates AI Security with Finovifi Tie-Up

Updated Category News Views 94

Emerging AI Risks and Protective Measures AI in financial spaces is like walking a tightrope, there's potential but caution is crucial. Enter Enigmata, diving headfirst into this arena by shaking hands with the Finovifi Marketplace. Their aim? To bolster AI's promise without letting sensitive data slip through the cracks. Sentinel: A New Guard for Sensitive Data Let's not...

Continue Reading
Medicare Limits and Long-Term Care Planning Tips

Updated Category News Views 36

Grappling with Medicare's Gaps Most folks hear Medicare and feel a sigh of relief—thinking it's a catch-all net for healthcare in your golden years. But hold on, when it comes to long-term care, Medicare's got more holes than Swiss cheese. Cindy Couyoumjian from Cinergy Financial lays it out pretty clear: Medicare doesn't cover what it calls 'custodial care'—you know,...

Continue Reading
Lincoln Educational Faces Investor Lawsuit Over Revenue Drop

Updated Category News Views 70

Investors Face Rough Waters Okay, let’s dive into this latest mess at Lincoln Educational Services Corp. (NASDAQ:LINC). Things aren't smelling too rosy over at their headquarters. If you've got shares here, you’ll know what I mean. Back in early May, the folks running Lincoln threw a garden party talking up a 19.5% growth in student starts. Who wouldn’t get behind...

Continue Reading
Amy Johnson Steps Up as GDIT President Amid Shifts

Updated Category News Views 68

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Continue Reading
Podcast Giants Converge in Tennessee for POD U Summit

Updated Category News Views 69

Nashville Becomes a Hotspot for Podcasters Amidst the strumming guitars and honky-tonk vibes of Nashville, Tennessee transformed into the epicenter of podcasting innovation thanks to Rebel Audio's inaugural summit, POD U. Here we had big names like Mike 'Big Mike' Majlak rubbing shoulders with sports experts and media moguls—a true concoction of voices shaping the...

Continue Reading
Dimethylaminopropylamine Market Eyes $732M by 2035

Updated Category News Views 21

Surfactants and Epoxy Fuel Dimethylaminopropylamine Demand Hot off the presses, folks! Dimethylaminopropylamine, or DMAPA if you're into acronyms, is gearing up for a steady climb to a $731.9 million market value by the year 2035. That's quite the leap from the $452.6 million we saw back in 2025. According to Credence Research's latest estimates, this amine is hitching...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 93

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading

Top 5 Most Recently Viewed Articles

Infosys and Sally Beauty Forge Groundbreaking IT Partnership

Updated Category News Views 165

Infosys has officially linked arms with Sally Beauty Holdings, Inc. to kick off a major IT transformation initiative. The aim? Ramp up enterprise-scale efficiencies through hyper-automation, putting Sally Beauty on the fast track for growth and keeping it competitive in a crowded beauty sector. You know how it goes when firms try to modernize—it's always a mixed bag,...

Continue Reading
HYLENR and TakeMe2Space Join Forces for Space Innovation

Updated Category News Views 324

HYLENR and TakeMe2Space Team Up for Space Exploration HYLENR Technologies, a frontrunner in clean energy solutions, has embarked on an exciting collaboration with the innovative space-tech company, TakeMe2Space. This partnership aims to explore the potential of Low-Energy Nuclear Reaction (LENR) technology for space-based computing infrastructures. Innovative...

Continue Reading
Convoy of Hope Sets Goal to Deliver Millions of Meals

Updated Category News Views 294

Convoy of Hope's Major Initiative to Support Families As families across America face difficulties in making ends meet, there's a growing need for assistance. For just $10, it's possible to provide 30 meals to those in need. Feeding Families Nationwide In response to the increasing needs of these families, Convoy of Hope has launched an impressive initiative to deliver 10...

Continue Reading
Transforming Diets: Pulses Market Growth and Insights

Updated Category News Views 207

The Flourishing Pulses Market Driven by Plant-Based Demand The global pulses market is experiencing significant growth, with projections estimating its value to rise from USD 78.0 billion in the coming years to USD 135.2 billion. This increase represents an impressive CAGR of 5.7% throughout the forecast period. The motivation behind this expansion is largely attributed...

Continue Reading
Understanding Windtree's New Istaroxime Patent for Heart Treatments

Updated Category News Views 123

Windtree's Istaroxime Patent Issuance: A Game Changer for Heart Failure Windtree Therapeutics, Inc., a pioneering biotech firm, recently celebrated a watershed moment with the issuance of a patent for istaroxime by the United States Patent and Trademark Office. This patent pertains to a unique intravenous formulation aimed at treating acute heart failure, an ailment that...

Continue Reading